ATE173014T1 - Afamin: ein menschliches serum albumin ähnliches protein - Google Patents

Afamin: ein menschliches serum albumin ähnliches protein

Info

Publication number
ATE173014T1
ATE173014T1 AT95915503T AT95915503T ATE173014T1 AT E173014 T1 ATE173014 T1 AT E173014T1 AT 95915503 T AT95915503 T AT 95915503T AT 95915503 T AT95915503 T AT 95915503T AT E173014 T1 ATE173014 T1 AT E173014T1
Authority
AT
Austria
Prior art keywords
human serum
protein
serum albumin
afamin
human
Prior art date
Application number
AT95915503T
Other languages
English (en)
Inventor
Henri Stephen Lichenstein
David Edwin Lyons
Mark Matsuo Wurfel
Samuel Donald Wright
Original Assignee
Amgen Inc
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Univ Rockefeller filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE173014T1 publication Critical patent/ATE173014T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95915503T 1994-03-31 1995-03-31 Afamin: ein menschliches serum albumin ähnliches protein ATE173014T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/222,619 US5652352A (en) 1994-03-31 1994-03-31 Afamin: a human serum albumin-like gene

Publications (1)

Publication Number Publication Date
ATE173014T1 true ATE173014T1 (de) 1998-11-15

Family

ID=22832990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95915503T ATE173014T1 (de) 1994-03-31 1995-03-31 Afamin: ein menschliches serum albumin ähnliches protein

Country Status (11)

Country Link
US (2) US5652352A (de)
EP (1) EP0754229B1 (de)
JP (1) JPH09511399A (de)
AT (1) ATE173014T1 (de)
AU (1) AU691607B2 (de)
CA (1) CA2186516A1 (de)
DE (1) DE69505804T2 (de)
DK (1) DK0754229T3 (de)
ES (1) ES2123973T3 (de)
MX (1) MX9604402A (de)
WO (1) WO1995027059A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US20060014143A1 (en) * 1995-06-07 2006-01-19 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US6410269B1 (en) * 1995-06-07 2002-06-25 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
US7208576B2 (en) * 1999-01-06 2007-04-24 Merrimack Pharmaceuticals, Inc. Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
AT407675B (de) * 1999-06-25 2001-05-25 Vita Tech Illmensee Dieplinger Verfahren zur fertilitätsbestimmung von säugetieren, insbesondere von menschen
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
EP2213743A1 (de) 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albuminfusionsproteine
AU2002335930B2 (en) * 2001-03-09 2005-07-28 Morphosys Ag Serum albumin binding moieties
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
AT411014B (de) * 2001-04-30 2003-09-25 Vitateq Biotechnology Gmbh Präparationen von vitamin e in kombination mit afamin
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
JP2006507477A (ja) * 2002-06-14 2006-03-02 ダイアックス、コープ タンパク質分析
JP4492156B2 (ja) * 2004-03-03 2010-06-30 ニプロ株式会社 血清アルブミンドメインを含む蛋白質
AT501348B1 (de) * 2005-01-31 2008-10-15 Vitateq Biotechnology Gmbh Verfahren zur tumordiagnose
JP5038407B2 (ja) * 2006-06-14 2012-10-03 ジョンズ ホプキンズ ユニバーシティー 疾患のバイオマーカーとしてのアルブミン結合性タンパク質／ペプチド複合体
AT505727B1 (de) * 2007-09-04 2009-06-15 Univ Innsbruck Verfahren zur diagnose des metabolischen syndroms
EP2726631A1 (de) 2011-06-28 2014-05-07 Vitateq Biotechnology GmbH Verfahren zur diagnose von präeklampsie
GB2511525A (en) * 2013-03-05 2014-09-10 Randox Teoranta Methods and Compositions for the Diagnosis of Alzheimer's Disease
JP2016188761A (ja) * 2013-08-23 2016-11-04 国立研究開発法人国立国際医療研究センター 糖尿病腎症の発症または発症リスクの検出方法及びキット
EP3037824A1 (de) 2014-12-22 2016-06-29 Vitateq Biotechnology GmbH Verfahren zur Detektion und/oder Quantifizierung von Afamin
EP3581584B1 (de) 2014-12-24 2022-03-30 Osaka University Verfahren zur herstellung von wnt-protein und verfahren zur lagerung von wnt-protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226551B (it) * 1988-07-29 1991-01-24 Sclavo Spa Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
US6268212B1 (en) * 1993-10-18 2001-07-31 Amgen Inc. Tissue specific transgene expression

Also Published As

Publication number Publication date
EP0754229A1 (de) 1997-01-22
CA2186516A1 (en) 1995-10-12
US5652352A (en) 1997-07-29
JPH09511399A (ja) 1997-11-18
WO1995027059A1 (en) 1995-10-12
DE69505804T2 (de) 1999-07-08
AU2236795A (en) 1995-10-23
EP0754229B1 (de) 1998-11-04
DE69505804D1 (de) 1998-12-10
US5767243A (en) 1998-06-16
ES2123973T3 (es) 1999-01-16
MX9604402A (es) 1997-07-31
DK0754229T3 (da) 1999-07-19
AU691607B2 (en) 1998-05-21

Similar Documents

Publication Publication Date Title
ATE173014T1 (de) Afamin: ein menschliches serum albumin ähnliches protein
ATE184052T1 (de) Gdf-1 und uog1 proteine
DE69738586D1 (de) Hohe expressionsrate von proteinen
DE69632546D1 (de) Ob proteinderivate mit verlängerter halbwertzeit
AU8747791A (en) Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis
WO1997020933A3 (en) Mutational variants of mammalian ob gene proteins
WO1996041868A3 (de) Prothrombin-derivate
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
DE69524971D1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
ATE139541T1 (de) Kollagen-bindendes protein sowie dessen herstellung
SE9602822D0 (sv) New receptor
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
WO1996016170A3 (en) Proteins involved in the regulation of cell-cell adhesion and uses thereof
WO1992011367A3 (en) Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
ATE317021T1 (de) Antisense modulierung von lfa-3
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof
ATE315646T1 (de) Leukocyten-aktivierender faktor
NZ503256A (en) Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors
SE9604439D0 (sv) New receptor
WO2001018194A3 (en) Maize casein kinase 1 orthologue and uses thereof
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
DE69012616D1 (de) Stabilisatoren mit N-hydroxy-substituierter, gehinderter Aminogruppe und ihre Herstellung durch Michael-Addition.
DK46293D0 (da) Et proteinbindende protein fra basidiomyceten antrodia sinuosa med en molykylevaegt paa ca. 29.000

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification